Promoter methylation of Wnt antagonist DKK1 gene and prognostic value in Korean patients with non-small cell lung cancers

Cancer Biomarkers

Volumn 12, Issue 2, 2012, Pages 73-79

  Na, Yeonkyung ^a   Lee, Su Man ^a   Kim, Dong Sun ^a   Park, Jae Yong ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

DKK1; Hypermethylation; MSP; NSCLC; prognosis

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; GENOMIC DNA; PROTEIN P53; T CELL FACTOR PROTEIN; VASCULOTROPIN RECEPTOR;

ADULT; ADVANCED CANCER; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; EARLY CANCER; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KOREA; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SMOKING; WNT SIGNALING PATHWAY;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; REPUBLIC OF KOREA; WNT SIGNALING PATHWAY;

EID: 84874302307     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-00295     Document Type: Article

References (39)

1. A. Jemal, R. Siegel, J. Xu and E.Ward, Cancer statistics 2010, CA Cancer J Clin 60 (2010), 277-300.
2. S. Toyook, K.O. Toyook, R. Maruyama et al., Methylation patterns of lung tumors, Mol Cancer Ther 1 (2001), 61-67.
3. K.M. Kerr, J.S. Galler, J.A. Hagen, P.W. Laird and I.A. Laird- Offringa, The role ofDNAmethylation in the development and progression in lung adenocarcinoma, Dis Markers 23 (2007), 5-30. (Pubitemid 46333646)
4. A.J. Alberg, M.V. Brock and J.M. Samet, Epidemiology of lung cancer: looking to the future, J Clin Oncol 23 (2005), 3175-3185. (Pubitemid 46217457)
5. A.F. Gazdar, H. Shigematsu and J. Herz and J.D. Minna, Mutations and addiction to EGFR: The Achilles 'heal' of lung cancers? Trends Mol Med 10 (2004), 481-486. (Pubitemid 39303620)
6. S. Toyooka, R. Maruyama and K.O. Toyooka et al., Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer, Int J Cancer 103 (2003), 153-160. (Pubitemid 35461506)
7. S.H. Jee, J.M. Samet,H.Ohrr, J.H.KimandI.S.Kim,Smoking and cancer risk in Korean men and women, Cancer Causes Control 15 (2004), 341-348. (Pubitemid 38988023)
8. P. Polakis, Wnt signaling and cancer, Genes Dev 14 (2000), 1837-1851. (Pubitemid 30639518)
9. J. Mazieres, B. He, L. You, Z. Xu and D.M. Joblons, Wnt signaling in lung cancer, Cancer Lett 222 (2005), 1-10. (Pubitemid 40544841)
10. Y. Kawano and R. Kypta, Secreted antagonists of the Wnt signaling pathway, J Cell Sci 116 (2003), 2627-2634. (Pubitemid 36857216)
11. A. Niida, T. Hiroko and M. Kasai, DKK1, a negative regulator of Wnt signaling, is a target of -catenin/TCF pathway, Oncogene 23 (2004), 8520-8526. (Pubitemid 39540802)
12. J.M. Gonzalez-Sancho, O. Aguilera, J.M. Garcia et al., The Wnt antagonist DICKKOPF-1 gene is a downstream target of -catenin/TCF and is downregulated in human colon cancer, Oncogene 24 (2005), 1098-1103. (Pubitemid 40313887)
13. O. Aguilera, M.F. Fraga, E. Ballestar et al., Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer, Oncogene 25 (2006), 4116-4121. (Pubitemid 44024874)
14. H. Sato, H. Suzuki, M. Toyota et al., Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors, Carcinogenesis 28 (2007), 2459-2466. (Pubitemid 350238947)
15. R. Suzuki, M. Onizuka, M. Kojima et al., Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukemia, Brit J Haematol 138 (2007), 624-631. (Pubitemid 47208475)
16. J.D. Licchesi, W.H.Westra, C.M. Hooker, E.O.Machida, S.B. Baylin and J.G.Herman, Epigenetic alteration ofWnt pathway antagonists in progressive glandular neoplasia of the lung, Carcinogenesis 29 (2008), 895-904. (Pubitemid 351982232)
17. H. Hirata, Y. Hinoda, K. Nakajima et al., Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma, Int J Cancer 128 (2011), 1793-1803.
18. M.A. Forget, S. Turcotte, D. Beauseigle et al., The Wnt pathway regulator DKK1 is preferentially expressed in hormoneresistant breast tumors and in some common cancer types, Brit J Cancer 96 (2007), 646-653.
19. T.Yamabuki, A. Takano, S. Hayama et al., Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas, Cancer Res 67 (2007), 2517-2525. (Pubitemid 46548936)
20. B. Yu, X. Yang, Y. Xu et al., Elevated expression of DKK1 is associated with cytoplasmic/nuclear catenin accumulation and poor prognosis in hepatocellular carcinoma. J Hepatol 50 (2009), 948-957.
21. N. Takahashi, T. Fukushima, K. Yorita, H. Tanaka, K. Chijiiwa and H. Kataoka, Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involve in invasive growth, Int J Cancer 126 (2010), 1611-1620.
22. S.Wang and S. Zhang, Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion, Clin Exp Metastasis 28 (2011), 581-591.
23. C.L. Hall, S.D. Daignault, R.B. Shah, K.J. Pienta and E.T. Keller, Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis, Prostate 68 (2008), 1396-1404.
24. S.M. Lee, J.Y. Lee, J.E. Choi, S.Y. Lee, J.Y. Park and D.S. Kim, Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathological features, Cancer Genet Cytogenet 197 (2010), 39-45.
25. M. Guo, M.G. House, C. Hooker et al., Promoter hypermethylation of resected bronchial margins: A field defect of changes? Clin Cancer Res 10 (2004), 5131-5136. (Pubitemid 39099787)
26. J. Mazieres, B. He, L. You et al., Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer, Cancer Res 64 (2004), 4717-4720. (Pubitemid 38924512)
27. T.M. Yang, S.W. Leu, J.M. Li et al., WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for nonsmall cell lung cancer-related malignant pleural effusions, J Cancer Res Clin Oncol 135 (2009), 919-924.
28. M. Yoshino, M. Suzuki, L. Tian et al., Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers, Int J Oncol 35 (2009), 1201-1209.
29. S.L. Sheng, G. Huang, B. Yu, W.X. Qin, Clinical significance and prognostic value of serum Dickkopf-1 concentration in patients with lung cancer, Clin Chem 55 (2009), 1656-1664.
30. M.E. Menezes, D.J. Devine, L.A. Shevde and R.S. Samant, Dickkopf1: A tumor suppressor or metastasis promoter? Int J Cancer 130 (2012), 1477-1483.
31. F. Hommura, K. Furuuchi, K. Yamazaki et al., Increased expression of -catenin predicts better prognosis in non small cell lung carcinomas, Cancer 94 (2002), 752-758. (Pubitemid 34133979)
32. J.M. Retera, M.P. Leers, M.A. Sulzer and P.H. Theunissen, The expression of -catenin in non-small cell lung cancer: A clinicopathogical study, J Clin Pathol 51 (1998), 891-894.
33. S. Kase, K. Sugio, K. Yamazaki, T. Okamoto, T. Yano and K. Sugimachi, Expression of E-cadherin and -catenin in human non-small cell lung cancer and the clinical significance, Clin Cancer Res 6 (2000), 4789-4796. (Pubitemid 32110421)
34. D.W. Ellison, O.E. Onilude, J.C. Lindsey et al., beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee, JClinOncol 23 (2005), 7951-7957. (Pubitemid 46657395)
35. D. Horst, S. Reu, L. Kriegl, J. Engel, T. Kirchner and A. Jung, The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer, Cancer 115 (2009), 2063-2070.
36. I. Arozarena, H. Bischof, D. Gilby, B. Belloni, R. Dummer and C. Wellbrock, In melanoma, beta-catenin is a suppressor of invasion, Oncogene 30 (2011), 4531-4543.
37. T. Hu and C. Li, Convergence between Wnt-catenin and EGFR signaling in cancer, Mol Cancer 9 (2010), 236-242.
38. H. Shigematsu and A.F. Gazdar, Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers, Int J Cancer 118 (2006), 257-262. (Pubitemid 41779062)
39. R. Wang, J. Ahmed, G. Wang, I. Hassan, Y. Strulovici- Barel, N.R. Hackett and R.G. Crystal, Down-regulation of the canonical Wnt -catenin pathway in the airway epithelium of healthy smokers and smokers with COPD, PLoS ONE 6 (2011), e14793.